As of 2024-12-12, the EV/EBITDA ratio of Bastide le Confort Medical SA (BLC.PA) is 5.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLC.PA's latest enterprise value is 543.98 mil EUR. BLC.PA's TTM EBITDA according to its financial statements is 106.51 mil EUR. Dividing these 2 quantities gives us the above BLC.PA EV/EBITDA ratio.
Range | Selected | |
Trailing P/E multiples | 5.7x - 8.1x | 6.8x |
Forward P/E multiples | 9.7x - 11.6x | 11.0x |
Fair Price | 30.39 - 105.56 | 70.93 |
Upside | 39.7% - 385.3% | 226.1% |
Date | EV/EBITDA |
2024-12-10 | 5.11 |
2024-12-09 | 5.09 |
2024-12-06 | 5.02 |
2024-12-05 | 5.05 |
2024-12-04 | 5.10 |
2024-12-03 | 5.06 |
2024-12-02 | 5.06 |
2024-11-29 | 5.04 |
2024-11-28 | 5.05 |
2024-11-27 | 5.00 |
2024-11-26 | 4.97 |
2024-11-25 | 4.99 |
2024-11-22 | 4.96 |
2024-11-21 | 4.94 |
2024-11-20 | 4.98 |
2024-11-19 | 4.91 |
2024-11-18 | 4.94 |
2024-11-15 | 4.95 |
2024-11-14 | 4.80 |
2024-11-13 | 4.82 |
2024-11-12 | 4.83 |
2024-11-11 | 4.84 |
2024-11-08 | 4.84 |
2024-11-07 | 4.85 |
2024-11-06 | 4.85 |
2024-11-05 | 4.86 |
2024-11-04 | 4.86 |
2024-11-01 | 4.85 |
2024-10-31 | 4.85 |
2024-10-30 | 4.88 |
2024-10-29 | 4.90 |
2024-10-28 | 4.92 |
2024-10-25 | 4.90 |
2024-10-24 | 4.92 |
2024-10-23 | 4.97 |
2024-10-22 | 4.99 |
2024-10-21 | 4.99 |
2024-10-18 | 4.99 |
2024-10-17 | 4.98 |
2024-10-16 | 4.97 |
2024-10-15 | 4.98 |
2024-10-14 | 4.97 |
2024-10-11 | 4.97 |
2024-10-10 | 5.00 |
2024-10-09 | 5.02 |
2024-10-08 | 5.02 |
2024-10-07 | 4.99 |
2024-10-04 | 4.98 |
2024-10-03 | 4.95 |
2024-10-02 | 4.97 |